UNITED STATES

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

Form 10-Q

☒ Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

For the quarterly period ended ~~October~~January 31, ~~2024~~2025

☐ Transition Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

For the transition period from __________ to __________

Registration No. 333-274889

NAPLOY CORP.

(Exact name of registrant as specified in its charter)

Wyoming	35-2809754	8000
State or Other Jurisdiction of	IRS Employer	Primary Standard Industrial
Incorporation or Organization	Identification Number	Classification Code Number

95 Lias Estate Kafe district Abuja,

FCT 900108 Nigeria

Telephone: +13072133163

Email: naploy.corp@tutanota.com

(Address and telephone number of principal executive offices)

Securities registered under Section 12(b) of the Exchange Act:

Title of each class	Trading Symbol	Name of each exchange on which registered
N/A	N/A	N/A

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15 (d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. ~~Yes ☒ No ☐~~

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).

Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).

Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer”, “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act:

Large accelerated filer	☐	Accelerated filer	☐
Non-accelerated filer	☒	Smaller reporting company	☒
		Emerging growth company	☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☒

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

State the number of shares outstanding of each of the issuer's classes of common equity, as of the latest practicable date: 3,803,370 common shares issued and outstanding as of ~~December~~January 0331, ~~2024~~2025.

TABLE OF CONTENTS

		Page
PART I	FINANCIAL INFORMATION:
Item 1.	Financial Statements (Unaudited)	3
	Balance Sheet as of October 31, 2024 (Unaudited) and July 31, 2024	4
	Balance Sheet as of January 31, 2025 (Unaudited) and July 31, 2024	4
	Statements of Operations for the three months ended October 31, 2024 and 2023 (Unaudited)	5
	Statements of Operations for the three and six months ended January 31, 2025 and 2024 (Unaudited)	5
	Statements of Stockholders’ Equity for the three months ended October 31, 2024 and 2023 (Unaudited)	6
	Statements of Stockholders’ Equity for the three and six months ended January 31, 2025 and 2024 (Unaudited)	6
	Statements of Cash Flows for the three months ended October 31, 2024 and 2023 (Unaudited)	7
	Statements of Cash Flows for the six months ended January 31, 2025 and 2024 (Unaudited)	7
	Notes to the Unaudited Financial Statements	8
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	1312
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	2119
Item 4.	Controls and Procedures	2119
PART II	OTHER INFORMATION:
Item 1.	Legal Proceedings	2220
Item 1A.	Risk Factors	2220
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	2220
Item 3.	Defaults Upon Senior Securities	2220
Item 4.	~~Submission~~Mine ofSafety ~~Matters to a Vote of Securities Holders~~Disclosures	2220
Item 5.	Other Information	2220
Item 6.	Exhibits	2220
	Signatures	2321

PART 1I – FINANCIAL INFORMATION

Item 1.

Financial Statements

The accompanying interim financial statements of Naploy Corp. (“the Company”, “we”, “us” or “our”), have been prepared without audit pursuant to the rules and regulations of the Securities and Exchange Commission.

The interim financial statements are condensed and should be read in conjunction with the company’s latest annual financial statements.

In the opinion of management, the financial statements contain all material adjustments, consisting only of normal adjustments considered necessary to present fairly the financial condition, results of operations, and cash flows of the Company for the interim periods presented.

NAPLOY CORP.

BALANCE SHEETS

	October 31, 2024 (Unaudited)			July 31, 2024 (Audited)
	January 31, 2025 (Unaudited)			July 31, 2024 (Audited)
ASSETS
Cash	$	27,~~728~~474		$	32,345
Total Current Assets		27,~~728~~474			32,345
Intangible Assets, Net		3331,~~375~~125			35,625
Total Assets	$	6158,~~103~~599		$	67,970
LIABILITIES & STOCKHOLDERS EQUITY/(DEFICIT)
Accounts Payable – Related Party	$	59,~~759~~822		$	59,759
Deferred Revenue		12,~~819~~681			–
Total Current Liabilities		6162,~~578~~503			59,759
Common stock, $0.0001 par value, 75,000,000 shares authorized; 3,803,370 and 3,734,620 shares issued and outstanding as of October 31, 2024 and July 31, 2024, respectively		380			373
Common stock, $0.0001 par value, 75,000,000 shares authorized; 3,803,370 and 3,734,620 shares issued and outstanding as of January 31, 2025 and July 31, 2024, respectively		380			373
Additional Paid in Capital		35,887			34,519
Accumulated deficit		(3640,~~742~~171	)		(26,681	)
Total Stockholders’ Equity/(Deficit)		(~~475~~3,904	)		8,211
Total Liabilities and Stockholders’ Equity/(Deficit)	$	6158,~~103~~599		$	67,970

The accompanying notes are an integral part of these unaudited financial statements.

NAPLOY CORP.

STATEMENTS OF OPERATIONS

	Three months period ended October 31, 2024 (Unaudited)			Three months period ended October 31, 2023 (Unaudited)
REVENUES
Services Sales	$	581		$	–
Total Revenues		581			–
OPERATING EXPENSES
Depreciation Expense		2,250			2,250
General and Administrative Expenses		27			33
Professional Fees		8,365			750
TOTAL OPERATING EXPENSES		(10,642	)		(3,033	)
NET INCOME (LOSS) FROM OPERATIONS		(10,061	)		(3,033	)
PROVISION FOR INCOME TAXES		–			–
NET INCOME (LOSS)	$	(10,061	)	$	(3,033	)
NET LOSS PER SHARE: BASIC AND DILUTED	$	(0.00	)	$	(0.00	)
WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING: BASIC AND DILUTED		3,782,793			2,000,000

Three and six months ended January 31, 2025 and 2024

The accompanying notes are an integral part of these unaudited financial statements.

	Three months period ended January 31, 2025 (Unaudited)			Three months period ended January 31, 2024 (Unaudited)			Six months period ended January 31, 2025 (Unaudited)			Six months period ended January 31, 2024 (Unaudited)

REVENUES
Services Sales	$	2,139		$	–		$	2,719		$	–
Total Revenues		2,139			–			2,719			–

OPERATING EXPENSES
Amortization Expense		2,250			2,250			4,500			4,500
General and Administrative Expenses		24			1			50			34
Professional Fees		3,294			3,768			11,659			4,518
TOTAL OPERATING EXPENSES		5,568			6,019			16,209			9,052

NET INCOME (LOSS) FROM OPERATIONS		(3,429	)		(6,019	)		(13,490	)		(9,052	)

PROVISION FOR INCOME TAXES		–			–			–			–

NET INCOME (LOSS)	$	(3,429	)	$	(6,019	)	$	(13,490	)	$	(9,052	)

NET LOSS PER SHARE: BASIC AND DILUTED	$	(0.00	)	$	(0.00	)	$	(0.00	)	$	(0.00	)

WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING: BASIC AND DILUTED		3,803,370			2,000,000			3,793,193			2,000,000

5The accompanying notes are an integral part of these unaudited financial statements.

~~NAPLOY CORP.~~5

~~STATEMENTS~~NAPLOY ~~OF STOCKHOLDERS’ EQUITY~~CORP.

~~Three~~STATEMENTS ~~months~~OF ~~ended~~STOCKHOLDERS’ ~~October 31, 2024 and 2023~~ EQUITY

~~(Unaudited)~~Three and six months ended January 31, 2025 and 2024

	Common Stock				Additional Paid-in		Accumulated			Total Stockholders’
	Shares		Amount		Capital		Deficit			Equity (Deficit)
Balance, July 31, 2024		3,734,620	$	373	$	34,519	$	(26,681	)	$	8,211
Shares issued for cash		68,750		7		1,368		–			1,375
Net loss for the three months ended October 31, 2024		–		–		–		(10,061	)		(10,061	)
Balance, October 31, 2024		3,803,370	$	380	$	35,887	$	(36,742	)	$	(475	)
Balance, July 31, 2023		2,000,000	$	200	$	–	$	(6,380	)	$	(6,180	)
Net loss for the three months ended October 31, 2023		–		–		–		(3,033	)		(3,033	)
Balance, October 31, 2023		2,000,000	$	200	$	–	$	(9,413	)	$	(9,213	)

(Unaudited)

The accompanying notes are an integral part of these unaudited financial statements.


	Common Stock				Additional Paid-in		Accumulated			Total Stockholders’ Equity
	Shares		Amount		Capital		Deficit			(Deficit)
Balance, October 31, 2024		3,803,370	$	380	$	35,887	$	(36,742	)	$	(475	)

Net loss for the three months ended January 31, 2025		–		–		–		(3,429	)		(3,429	)

Balance, January 31, 2025		3,803,370	$	380	$	35,887	$	(40,171	)	$	(3,904	)



Balance, October 31, 2023		2,000,000	$	200	$	–	$	(9,413	)	$	(9,213	)

Net loss for the three months ended January 31, 2024		–		–		–		(6,019	)		(6,019	)

Balance, January 31, 2024		2,000,000	$	200	$	–	$	(15,432	)	$	(15,232	)



Balance, July 31, 2024		3,734,620	$	373	$	34,519	$	(26,681	)	$	8,211

Shares issued for cash		68,750		7		1,368		–			1,375

Net loss for the six months ended January 31, 2025		–		–		–		(13,490	)		(13,490	)

Balance, January 31, 2025		3,803,370	$	380	$	35,887	$	(40,171	)	$	(3,904	)



Balance, July 31, 2023		2,000,000	$	200	$	–	$	(6,380	)	$	(6,180	)

Net loss for the six months ended January 31, 2024		–		–		–		(9,052	)		(9,052	)

Balance, January 31, 2024		2,000,000	$	200	$	–	$	(15,432	)	$	(15,232	)

6The accompanying notes are an integral part of these unaudited financial statements.

~~NAPLOY CORP.~~6

~~STATEMENTS~~NAPLOY ~~OF CASH FLOWS~~CORP.

	Three months ended October 31, 2024 (Unaudited)			Three months ended October 31, 2023 (Unaudited)
CASH FLOWS FROM OPERATING ACTIVITIES
Net income (loss)	$	(10,061	)	$	(3,033	)
Amortization Expense		2,250			2,250
Accounts Payable		–			(5,700	)
Deferred Revenue		1,819			–
CASH FLOWS USED IN OPERATING ACTIVITIES		(5,992	)		(6,483	)
CASH FLOWS FROM INVESTING ACTIVITIES
Mobile Application and Website Acquisition		–			(20,000	)
CASH FLOWS PROVIDED BY INVESTING ACTIVITIES		–			(20,000	)
CASH FLOWS FROM FINANCING ACTIVITIES
Accounts Payable - Related Party Loans		–			30,100
Proceeds from Sale of Common Stock		1,375			–
CASH FLOWS PROVIDED BY FINANCING ACTIVITIES		1,375			30,100
Net increase in cash and equivalents		(4,617	)		3,617
Cash and equivalents at beginning of the period		32,345			895
Cash and equivalents at end of the period	$	27,728		$	4,512
Supplemental cash flow information:
Non-cash investing and financing activity:
Mobile Application and Website Acquisition	$	–		$	(20,000	)
Cash paid for:
Interest	$	–		$	–
Taxes	$	–		$	–

STATEMENTS OF CASH FLOWS

~~The~~Six ~~accompanying~~months ~~notes~~ended ~~are~~January an31, ~~integral~~2025 ~~part~~and ~~of these unaudited financial statements.~~2024

	Six months ended January 31, 2025 (Unaudited)			Six months ended January 31, 2024 (Unaudited)
CASH FLOWS FROM OPERATING ACTIVITIES
Net income (loss)	$	(13,490	)	$	(9,052	)
Amortization Expense		4,500			4,500
Accounts Payable		–			(5,700	)
Deferred Revenue		2,681			–
CASH FLOWS USED IN OPERATING ACTIVITIES		(6,309	)		(10,252	)

CASH FLOWS FROM INVESTING ACTIVITIES
Mobile Application and Website Acquisition		–			(20,000	)
CASH FLOWS PROVIDED BY INVESTING ACTIVITIES		–			(20,000	)

CASH FLOWS FROM FINANCING ACTIVITIES
Accounts Payable - Related Party Loans		63			30,100
Proceeds from Sale of Common Stock		1,375			–
CASH FLOWS PROVIDED BY FINANCING ACTIVITIES		1,438			30,100

Net increase in cash and equivalents		(4,871	)		(152	)
Cash and equivalents at beginning of the period		32,345			895
Cash and equivalents at end of the period	$	27,474		$	743

Supplemental cash flow information:

Non-cash investing and financing activity:
Mobile Application and Website Acquisition	$	–		$	(20,000	)

Cash paid for:
Interest	$	–		$	–
Taxes	$	–		$	–

~~NAPLOY~~The ~~CORP~~accompanying notes are an integral part of these unaudited financial statements.

~~NOTES TO THE UNAUDITED FINANCIAL STATEMENTS~~ 7

~~THREE~~NAPLOY ~~MONTHS ENDED OCTOBER 31, 2024 AND 2023~~CORP.

~~NOTE~~NOTES 1TO –THE ~~ORGANIZATION~~UNAUDITED ~~AND~~FINANCIAL ~~BASIS OF PRESENTATION~~STATEMENTS

~~Naploy~~SIX ~~Corp.~~MONTHS ~~(referred~~ENDED asJANUARY ~~the “Company”~~31, ~~“we”,~~ ~~“our”)~~2025 ~~was~~AND incorporated in the State of Wyoming and established on April 6, 2023. Our primary focus is on launching a news blog that provides the latest updates on health-related topics, including but not limited to medical breakthroughs, healthy lifestyle tips, and updates on healthcare policies.2024

NOTE 21 – ~~GOING~~ ~~CONCERN~~ORGANIZATION AND BASIS OF PRESENTATION

~~The~~Naploy ~~Company’s~~Corp. ~~financial~~(referred ~~statements~~as ~~have~~the “Company”, ~~been~~“we”, ~~prepared~~“our”) ~~assuming~~was ~~that~~incorporated itin ~~will~~the ~~continue~~State asof aWyoming ~~going~~and ~~concern,~~established ~~which~~on ~~contemplates~~April ~~continuity~~6, of2023. ~~operations,~~Our ~~realization~~primary offocus ~~assets,~~is ~~and~~on ~~liquidation~~launching ofa ~~liabilities~~news inblog that provides the ~~normal~~latest ~~course~~updates ofon ~~business~~health-related topics, including but not limited to medical breakthroughs, healthy lifestyle tips, and updates on healthcare policies.

AsNOTE ~~reflected~~2 in– ~~the~~GOING financial statements, the Company had an accumulated deficit of $36,742 at October 31, 2024, a net loss of $10,061 for the three months ended October 31, 2024. These factors raise substantial doubt about the Company’s ability to continue as a going concern.CONCERN

The Company ~~is attempting to commence operations and generate sufficient revenue; however, the Company~~’s ~~cash~~financial ~~position~~statements ~~may not be sufficient to support the Company’s daily~~have ~~operations.~~been ~~Management~~prepared ~~intends~~assuming tothat ~~raise~~it ~~additional~~will ~~funds~~continue byas ~~way of~~ a ~~private~~going orconcern, ~~public~~which ~~offering.~~contemplates ~~While~~continuity ~~the Company believes in the viability~~ of ~~its strategy to commence~~ operations, ~~and~~realization ~~generate~~of ~~sufficient revenue and in its ability to raise additional funds~~assets, ~~there can be no assurances~~and toliquidation ~~that effect. The ability~~ of ~~the~~liabilities ~~Company~~in ~~to continue as a going concern is dependent upon~~ the ~~Company’s~~normal ~~ability~~course ~~to further implement its business plan and generate sufficient revenue and its ability to raise additional funds by way~~ of ~~a public or private offering~~business.

~~The~~As reflected in the financial statements, dothe Company ~~not~~had ~~include~~an ~~any~~accumulated ~~adjustments related~~deficit toof ~~the~~$40,171 ~~recoverability~~at ~~and~~January ~~classification~~31, of2025, ~~recorded~~a ~~asset~~net ~~amounts~~loss orof $13,490 for the ~~amounts~~six ~~and~~months ~~classification~~ended ofJanuary ~~liabilities~~31, ~~that~~2025. ~~might~~These befactors ~~necessary~~raise ~~should~~substantial doubt about the Company’s beability ~~unable~~ to continue as a going concern.

~~NOTE~~The 3Company –is ~~SUMMARY~~attempting OFto ~~SIGNIFICANT~~commence ~~ACCOUNTING~~operations ~~POLICIES~~and generate sufficient revenue; however, the Company’s cash position may not be sufficient to support the Company’s daily operations. Management intends to raise additional funds by way of a private or public offering. While the Company believes in the viability of its strategy to commence operations and generate sufficient revenue and in its ability to raise additional funds, there can be no assurances to that effect. The ability of the Company to continue as a going concern is dependent upon the Company’s ability to further implement its business plan and generate sufficient revenue and its ability to raise additional funds by way of a public or private offering.

~~Basis~~The financial statements do not include any adjustments related to the recoverability and classification of ~~Presentation~~recorded asset amounts or the amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.

~~The~~NOTE ~~accompanying~~3 ~~financial statements~~– ~~have~~SUMMARY ~~been~~OF ~~prepared~~SIGNIFICANT ~~in accordance with generally accepted accounting principles in the United States of America.~~ACCOUNTING POLICIES

~~The~~Basis ~~Company’s~~of ~~year-end is~~Presentation ~~July 31.~~

~~Interim~~The ~~Financial~~accompanying ~~Statements~~financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America.

The ~~unaudited interim financial statements of the~~ Company have been prepared in accordance with accounting principles generally accepted in the United States for interim financial information and the instructions to Form 10-Q and Rule 8-03 of Regulation S-X. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. The results of operations for such periods are not necessarily indicative of the results expected for a full year or for any future period. Therefore, these financial statements should be read in conjunction with the Company’s ~~audited financial statements and notes filed with the SEC for the~~ year-end ~~ended~~is July ~~31,~~ ~~2024~~31.

8Interim Financial Statements

~~Development~~The ~~Stage~~unaudited interim financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States for interim financial information and the instructions to Form 10-Q and Rule 8-03 of Regulation S-X. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. The results of operations for such periods are not necessarily indicative of the results expected for a full year or for any future period. Therefore, these financial statements should be read in conjunction with the Company’s audited financial statements and notes filed with the SEC for the year ended July 31, 2024.

~~The Company is a development stage company as defined in ASC 915 “~~Development Stage ~~Entities”. The~~ Company is devoting substantially all of its efforts on establishing the business and its planned principal operations have not commenced. All losses accumulated since Inception has been considered as part of the Company’s development stage activities.

The Company ~~has~~is ~~elected~~a todevelopment ~~adopt~~stage ~~application~~company ofas ~~Accounting~~defined ~~Standards~~in ~~Update~~ASC ~~No.~~915 ~~2014-10,~~ “Development Stage Entities”. ~~(Topic~~The ~~915):~~Company ~~Elimination~~is devoting substantially all of ~~Certain~~its ~~Financial~~efforts ~~Reporting~~on ~~Requirements.~~establishing ~~Upon~~the ~~adoption,~~business ~~the~~and ~~Company~~its noplanned ~~longer~~principal ~~presents~~operations orhave ~~discloses~~not ~~inception-to-date~~commenced. ~~information~~All ~~and~~losses ~~other~~accumulated ~~remaining~~since ~~disclosure~~Inception ~~requirements~~has ofbeen considered as part ~~Topic~~of ~~915~~the Company’s development stage activities.

~~Use~~The Company has elected to adopt application of Accounting ~~Estimates~~Standards Update No. 2014-10, Development Stage Entities (Topic 915): Elimination of Certain Financial Reporting Requirements. Upon adoption, the Company no longer presents or discloses inception-to-date information and other remaining disclosure requirements of Topic 915.

The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date the financial statements and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates.8

~~Cash~~Use ~~and~~of ~~Cash Equivalents~~Estimates

The ~~Company~~preparation ~~considers~~of ~~all~~financial ~~highly~~statements ~~liquid~~in ~~investments~~conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the ~~original~~reported ~~maturities~~amounts of assets ~~three~~and ~~months~~liabilities orand ~~less~~disclosure toof becontingent ~~cash~~assets ~~equivalents~~and liabilities at the date the financial statements and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates.

~~Our cash is held in a Wise electronic money account. In accordance with ASC 230-10-20, Statement of~~ Cash ~~Flows, the Company has determined that the cash held in the Wise electronic money account should be classified as cash because it is readily available for the payment of obligations,~~ and ~~free~~Cash ~~from any contractual restriction that limits its use.~~Equivalents

~~Our~~The Company ~~holds~~considers ~~its~~all ~~cash~~highly ~~and~~liquid ~~cash equivalents~~investments ~~in accounts~~ with ~~Wise,~~the aoriginal ~~financial~~maturities ~~technology~~of ~~company~~three ~~specializing~~months inor ~~international~~less ~~money transfers. It is important~~ to ~~note~~be ~~that~~cash ~~Wise is not a bank, but rather a licensed and regulated financial services provider~~equivalents.

~~Wise~~Our ~~operates~~cash ~~under~~is ~~regulatory~~held ~~frameworks~~in ~~and~~a Wise electronic money account. isIn ~~subject~~accordance towith ~~oversight~~ASC by230-10-20, ~~various~~Statement ~~financial~~of ~~regulatory~~Cash ~~authorities.~~Flows, ~~While~~the itCompany ~~provides~~has ~~services~~determined that ~~are~~the ~~similar~~cash toheld ~~traditional~~in ~~banks,~~the Wise electronic money itaccount ~~does~~should ~~not~~be ~~operate~~classified as acash ~~traditional~~because ~~bank~~it ~~and~~ is ~~not~~readily aavailable ~~member~~for the payment of ~~the~~obligations, ~~Federal~~and ~~Deposit~~free ~~Insurance~~from ~~Corporation~~any ~~(FDIC)~~contractual restriction that limits its use.

~~Investors~~Our ~~should~~Company beholds ~~aware~~its ~~that,~~cash ~~unlike~~and ~~traditional~~cash equivalents ~~banks~~in ~~covered~~accounts bywith ~~the FDIC~~Wise, ~~Wise~~a ~~accounts~~financial dotechnology ~~not~~company ~~offer~~specializing ~~deposit~~in ~~insurance.~~international ~~The~~money ~~absence~~transfers. ofIt ~~FDIC~~is ~~coverage~~important ~~means~~to note that ~~the~~Wise is ~~funds~~not ~~held~~a inbank, ~~Wise accounts~~but ~~are~~rather ~~not~~a ~~protected~~licensed upand toregulated ~~the~~financial ~~standard~~services ~~FDIC-insured limit~~provider.

~~Our~~Wise ~~cash~~operates under regulatory frameworks and is ~~held~~subject ~~exclusively~~to inoversight aby ~~Wise~~various ~~electronic money~~financial ~~account~~regulatory authorities. ~~Funds~~While ~~held~~it inprovides ~~Wise~~services ~~accounts~~that are similar to traditional banks, it does not ~~insured~~operate byas a traditional bank and is not a member of the Federal Deposit Insurance Corporation (FDIC) ~~or any other deposit protection scheme~~.

~~Over~~Investors ~~99%~~should ofbe ~~Wise’s~~aware ~~funds~~that, ~~are~~unlike ~~held in cash~~traditional ~~with these~~ banks ~~(GOLDMAN~~covered ~~SACHS~~by ~~BANK~~the ~~USA~~FDIC, ~~JPMORGAN~~Wise ~~CHASE~~accounts ~~BANK,~~do ~~N.A.,~~not ~~WELLS~~offer ~~FARGO~~deposit ~~BANK, N~~insurance.~~A.,~~ USThe ~~Government~~absence ~~bonds)~~of asFDIC ~~well~~coverage asmeans inthat ~~secure liquid~~the ~~assets~~funds ~~such~~held ~~as EU, UK and US Government bonds~~ in ~~order to diversify risk and maximise liquidity.~~ Wise accounts ~~takes~~are ~~this~~not ~~approach~~protected up to ~~make sure~~ the ~~money~~standard isFDIC-insured ~~highly liquid and therefore always available to clients~~limit.

Our ~~choice~~cash tois ~~utilize~~held ~~Wise~~exclusively ~~aligns~~in ~~with~~a ~~our~~Wise ~~commitment~~electronic tomoney ~~leveraging~~account. ~~innovative~~Funds ~~and~~held ~~efficient~~in ~~financial~~Wise ~~services~~accounts ~~while~~are ~~remaining~~not ~~transparent~~insured ~~about~~by the ~~associated~~Federal ~~regulatory~~Deposit ~~and~~Insurance ~~insurance~~Corporation ~~considerations~~(FDIC) or any other deposit protection scheme.

AsOver ~~the~~99% ~~company~~of isWise’s ~~incorporated~~funds inare ~~and~~held ~~under~~in ~~the~~cash ~~laws~~with ofthese ~~the~~banks ~~United~~(GOLDMAN ~~States~~SACHS BANK USA, weJPMORGAN ~~are~~CHASE ~~considered~~BANK, N.A., WELLS FARGO BANK, N.A., US Government bonds) as ~~the~~well ~~American~~as ~~customer~~in ofsecure liquid ~~Wise~~assets such as EU, UK and ~~fall~~US ~~under~~Government ~~the~~bonds ~~jurisdiction~~in oforder ~~the~~to ~~agreement~~diversify ~~for~~risk ~~the~~and maximise liquidity. Wise takes this approach to make ~~USA~~sure ~~customers~~the money is highly liquid and therefore always available to clients.

9Our choice to utilize Wise aligns with our commitment to leveraging innovative and efficient financial services while remaining transparent about the associated regulatory and insurance considerations.

~~Fair~~As ~~Value~~the company is incorporated in and under the laws of ~~Financial~~the United States, we are considered as the American customer of Wise and fall under the jurisdiction of the agreement for the ~~Instruments~~USA customers.

~~AS topic 820 “~~Fair Value ~~Measurements~~of ~~and Disclosures”~~Financial establishes a three-tier fair value hierarchy, which prioritizes the inputs in measuring fair value. The hierarchy prioritizes the inputs into three levels based on the extent to which inputs used in measuring fair value are observable in the market.Instruments

~~These~~AS ~~tiers~~topic ~~include:~~820 “Fair Value Measurements and Disclosures” establishes a three-tier fair value hierarchy, which prioritizes the inputs in measuring fair value. The hierarchy prioritizes the inputs into three levels based on the extent to which inputs used in measuring fair value are observable in the market.

Level 1:	defined as observable inputs such as quoted prices in active markets;
Level 2:	defined as inputs other than quoted prices in active markets that are either directly or indirectly observable; and
Level 3:	defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions.

These tiers include:

The carrying value of cash and the Company’s loan from shareholder approximates its fair value due to their short-term maturity.

Level 1:	defined as observable inputs such as quoted prices in active markets;
Level 2:	defined as inputs other than quoted prices in active markets that are either directly or indirectly observable; and
Level 3:	defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions.

~~Foreign~~The ~~Currency~~carrying value of cash and the Company’s loan from shareholder approximates its fair value due to their short-term maturity.

The Company’s functional and reporting currency is the U.S. dollar. Transactions may occur in foreign currencies and management follows ASC 830, “Foreign Currency Matters”. Monetary assets and liabilities denominated in foreign currencies are translated using the exchange rate prevailing at the balance sheet date. Non-monetary assets and liabilities denominated in foreign currencies are translated at rates of exchange in effect at the date of the transaction. Average monthly rates are used to translate revenues and expenses. Gains and losses arising on translation or settlement of foreign currency denominated transactions or balances are included in the Statement of Operations. Naploy Corp. has no subsidiaries located outside the United States.9

~~Income~~Foreign ~~Taxes~~Currency

~~Income~~The ~~taxes~~Company’s ~~are~~functional ~~computed~~and ~~using~~reporting currency is the ~~asset~~U.S. ~~and liability method~~dollar. ~~Under~~Transactions ~~the~~may ~~asset~~occur in foreign currencies and ~~liability~~management ~~method~~follows ASC 830, ~~deferred~~“Foreign ~~income~~Currency ~~tax~~Matters”. Monetary assets and liabilities ~~are~~denominated ~~determined~~in ~~based~~foreign oncurrencies ~~the~~are ~~differences between~~translated using the ~~financial~~exchange ~~reporting~~rate ~~and~~prevailing ~~tax~~at ~~bases~~the ofbalance sheet date. Non-monetary assets and liabilities ~~and~~denominated in foreign currencies are ~~measured~~translated ~~using~~at rates of exchange in effect at the ~~currently~~date of ~~enacted~~the ~~tax~~transaction. Average monthly rates are used to translate revenues and ~~laws~~expenses. A ~~valuation~~Gains ~~allowance~~and islosses ~~provided~~arising ~~for~~on ~~the~~translation ~~amount~~or settlement of ~~deferred~~foreign ~~tax~~currency ~~assets~~denominated ~~that,~~transactions ~~based~~or onbalances ~~available~~are ~~evidence,~~included ~~are~~in ~~not~~the ~~expected~~Statement toof beOperations. ~~realized~~Naploy Corp. has no subsidiaries located outside the United States.

~~Basic~~ Income ~~(Loss) Per Share~~Taxes

~~The~~Income ~~Company~~taxes ~~computes~~are ~~income~~computed ~~(loss)~~using ~~per~~the ~~share~~asset inand ~~accordance~~liability ~~with~~method. ~~FASB~~Under ~~ASC~~the ~~260~~asset ~~“Earnings~~and ~~per~~liability ~~Share”.~~method, ~~Basic~~deferred ~~loss~~income ~~per~~tax ~~share~~assets isand ~~computed~~liabilities byare ~~dividing~~determined ~~net~~based ~~income~~on ~~(loss)~~the ~~available~~differences tobetween ~~common~~the ~~shareholders~~financial byreporting ~~the~~and ~~weighted~~tax ~~average~~bases ~~number~~ of ~~outstanding~~assets ~~common~~and ~~shares~~liabilities ~~during~~and ~~the~~are ~~period.~~measured ~~Diluted~~using ~~income~~the ~~(loss)~~currently ~~per~~enacted ~~share gives~~tax ~~effect~~rates toand ~~all~~laws. A ~~dilutive~~valuation ~~potential~~allowance ~~common~~is ~~shares~~provided ~~outstanding~~for ~~during~~ the ~~period.~~amount ~~Dilutive~~of ~~loss~~deferred ~~per~~tax ~~share~~assets ~~excludes~~that, ~~all~~based ~~potential~~on ~~common shares~~available ifevidence, ~~their~~are ~~effect~~not isexpected ~~anti-dilutive~~to be realized.

AsBasic ofIncome ~~October~~(Loss) ~~31,~~Per ~~2024 and July 31, 2024, there were no potentially dilutive debt or equity instruments issued or outstanding.~~Share

~~Stock-Based~~The ~~Compensation~~Company computes income (loss) per share in accordance with FASB ASC 260 “Earnings per Share”. Basic loss per share is computed by dividing net income (loss) available to common shareholders by the weighted average number of outstanding common shares during the period. Diluted income (loss) per share gives effect to all dilutive potential common shares outstanding during the period. Dilutive loss per share excludes all potential common shares if their effect is anti-dilutive.

~~Stock-based~~As ~~compensation~~of isJanuary ~~accounted~~31, ~~for~~2025 atand ~~fair value~~July in31, ~~accordance with ASC Topic 718. To date~~2024, ~~the~~there were ~~Company~~no ~~has~~potentially ~~not~~dilutive ~~adopted~~debt aor ~~stock~~equity ~~option~~instruments ~~plan~~issued ~~and~~or ~~has not granted any stock options~~outstanding.

~~Recent~~Stock-Based ~~Accounting Pronouncements~~Compensation

~~Management~~Stock-based ~~does~~compensation ~~not~~is ~~believe~~accounted ~~that~~for ~~any~~at ~~recently~~fair ~~issued,~~value ~~but~~in ~~not~~accordance ~~yet~~with ~~effective~~ASC ~~accounting~~Topic ~~pronouncements,~~718. ~~when~~To ~~adopted~~date, ~~will~~the ~~have~~Company has not adopted a ~~material~~stock ~~effect~~option onplan ~~the~~and ~~accompanying~~has ~~financial~~not ~~statements~~granted any stock options.

10Recent Accounting Pronouncements

~~NOTE~~Management 4does –not ~~INTANGIBLE~~believe ~~ASSETS~~that any recently issued, but not yet effective accounting pronouncements, when adopted, will have a material effect on the accompanying financial statements.

~~The~~NOTE ~~Company~~4 ~~follows~~– ~~the~~INTANGIBLE provisions of ASC Subtopic 350-40, Internal-Use Software-Computer Software Developed or Obtained for Internal Use, which requires assets to be recorded at the cost to develop the asset and requires an intangible asset to be amortized over its useful life.ASSETS

InThe ~~June~~Company ~~2023~~follows the ~~Company~~provisions ~~acquired~~of ~~mobile~~ASC ~~application~~Subtopic ~~and~~350-40, ~~website~~Internal-Use Software-Computer Software Developed or Obtained for ~~$45~~Internal Use,~~000,~~ which isrequires ~~being~~assets ~~amortized~~to ~~over~~be arecorded ~~five-year~~at ~~life.~~the ~~The~~cost to ~~accumulated~~develop ~~amortization~~the ~~was~~asset ~~$11,625~~ and ~~$9,375~~requires asan ofintangible ~~October 31,~~asset ~~2024~~to ~~and~~be ~~July~~amortized ~~31,~~over ~~2024,~~its ~~respectively~~useful life.

~~NOTE~~In 5June –2023 the Company acquired mobile application ~~LOAN~~and ~~FROM~~website ~~RELATED~~for ~~PARTY~~$45,000, which is being amortized over a five-year life. The accumulated amortization was $13,875 and $9,375 as of January 31, 2025 and July 31, 2024, respectively.

AsNOTE of5 ~~October~~– ~~31,~~LOAN ~~2024,~~FROM ~~the~~RELATED Company had a loan outstanding with a related party: Mr. Rafael Angel Ulloa Bonilla, our Director, who has given us a loan in the amount of $59,759 for the Company’s working capital purposes. The amount is outstanding and payable upon request.PARTY

~~NOTE~~As 6of –January 31, 2025, the Company had a loan ~~COMMON~~outstanding ~~STOCK~~with a related party: Mr. Rafael Angel Ulloa Bonilla, our Director, who has given us a loan in the amount of $59,822 for the Company’s working capital purposes. The amount is outstanding and payable upon request.

On April 6, 2023, the Company issued 2,000,000 shares of common stock to the director, Frederick Sidney Reinhard Arnold, at in consideration of $200 at $0.0001 per share to pay partial Incorporation fees expenses.10

~~During~~NOTE ~~the~~6 ~~year~~– ~~ended~~COMMON ~~July 31, 2024 the Company issued 1,734,620 shares of common stock for cash proceeds of $34,692 at $0.02 per share.~~STOCK

InOn ~~August~~April ~~2024~~7, 2023, the Company issued 352,000 ,000 shares of common stock ~~for cash~~to ~~proceeds~~the director, Frederick Sidney Reinhard Arnold, at in consideration of $~~700~~200 at $0.020001 per share to pay partial Incorporation fees expenses.

InDuring ~~September~~the year ended July 31, 2024 the Company issued 331,~~750~~734,620 shares of common stock for cash proceeds of $~~675~~34,692 at $0.02 per share.

AsIn ofAugust ~~October 31,~~ 2024 ~~and~~the ~~July~~Company ~~31,~~issued ~~2024~~35,000 ~~the~~shares ~~Company~~of ~~had~~common ~~3,803,370~~stock for ~~and~~cash ~~3,734,620~~proceeds ~~shares~~of ~~issued~~$700 ~~and~~at ~~outstanding,~~$0.02 ~~respectively~~per share.

~~NOTE~~In 7September –2024 ~~INCOME~~the ~~TAXES~~Company issued 33,750 shares of common stock for cash proceeds of $675 at $0.02 per share.

OnAs ~~December~~of ~~22,~~January ~~2017~~31, ~~the~~ ~~President~~2025 ~~of the United States signed into law the Tax Cuts~~ and ~~Jobs~~July ~~Act (“Tax Reform Act”). The legislation significantly changes U.S. tax law by~~31, ~~among other things~~2024, ~~lowering~~the ~~corporate~~Company ~~income~~had ~~tax rates~~3, ~~implementing a territorial tax system~~ 803,370 and ~~imposing a transition tax on deemed repatriated earnings of foreign subsidiaries. The Tax Reform Act permanently reduces the U.S. corporate income tax rate from a maximum of 35% to a flat 21% rate~~3, ~~effective January 1~~734,620 ~~2018.~~shares Asissued aand ~~result of the reduction in the U.S. corporate income tax rate from 34% to 21% under the Tax Reform Act~~outstanding, ~~the Company revalued its ending net deferred tax assets~~respectively.

~~The~~NOTE ~~reconciliation~~7 of– ~~income~~INCOME ~~tax benefit (expenses) at the U.S. statutory rate at 21% for the period ended as follows:~~TAXES

	October 31, 2024			July 31, 2024
Tax benefit (expenses) at U.S. statutory rate	$	(7,716	)	$	(5,603	)
Change in valuation allowance		7,716			5,603
Tax benefit (expenses) net	$	–		$	–

On December 22, 2017, the President of the United States signed into law the Tax Cuts and Jobs Act (“Tax Reform Act”). The legislation significantly changes U.S. tax law by, among other things, lowering corporate income tax rates, implementing a territorial tax system and imposing a transition tax on deemed repatriated earnings of foreign subsidiaries. The Tax Reform Act permanently reduces the U.S. corporate income tax rate from a maximum of 35% to a flat 21% rate, effective January 1, 2018. As a result of the reduction in the U.S. corporate income tax rate from 34% to 21% under the Tax Reform Act, the Company revalued its ending net deferred tax assets.

11The reconciliation of income tax benefit (expenses) at the U.S. statutory rate at 21% for the period ended as follows:

The tax effects of temporary differences that give rise to significant portions of the net deferred tax assets are as follows:

	January 31, 2025			July 31, 2024

Tax benefit (expenses) at U.S. statutory rate	$	(8,436	)	$	(5,603	)
Change in valuation allowance		8,436			5,603
Tax benefit (expenses) net	$	–		$	–

	October 31, 2024			July 31, 2024
Net operating loss	$	(7,716	)	$	(5,603	)
Valuation allowance		7,716			5,603
Deferred tax assets, net	$	–		$	–

The tax effects of temporary differences that give rise to significant portions of the net deferred tax assets are as follows:

The Company has accumulated approximately $36,742 of net operating losses (“NOL”) carried forward to offset future taxable income up to 20 years, if any, in future years which begin to expire in year 2040. In assessing the realization of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. Management considers the scheduled reversal of deferred tax liabilities, projected future taxable income and tax planning strategies in making this assessment. Based on the assessment, management has established a full valuation allowance against all of the deferred tax asset relating to NOLs for every period because it is more likely than not that all of the deferred tax asset will not be realized.

Schedule of deferred tax assets	January 31, 2025			July 31, 2024

Net operating loss	$	(8,436	)	$	(5,603	)
Valuation allowance		8,436			5,603
Deferred tax assets, net	$	–		$	–

~~NOTE~~The 8Company –has ~~SUBSEQUENT~~accumulated ~~EVENTS~~approximately $40,171 of net operating losses (“NOL”) carried forward to offset future taxable income up to 20 years, if any, in future years which begin to expire in year 2040. In assessing the realization of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. Management considers the scheduled reversal of deferred tax liabilities, projected future taxable income and tax planning strategies in making this assessment. Based on the assessment, management has established a full valuation allowance against all of the deferred tax asset relating to NOLs for every period because it is more likely than not that all of the deferred tax asset will not be realized.

InNOTE ~~accordance~~8 ~~with~~– ~~ASC 855-10~~SUBSEQUENT the Company has analyzed its operations subsequent to October 31, 2024 to the date these financial statements were issued, and has determined that it does not have any material subsequent events to disclose in these financial statements.EVENTS

12In accordance with ASC 855-10 the Company has analyzed its operations subsequent to January 31, 2025 to the date these financial statements were issued, and has determined that it does not have any material subsequent events to disclose in these financial statements.

~~ITEM 2. MANAGEMENT’ DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS~~11

~~DESCRIPTION~~Item OF2. ~~BUSINESS~~Management’s Discussion and Analysis of Financial Condition and Results of Operations

~~GENERAL~~DESCRIPTION OF BUSINESS

Naploy Corp. was incorporated in the State of Wyoming and established on April 6, 2023. The Company has limited revenue and incurred losses since inception. Our primary focus is on launching a news blog that provides the latest updates on health-related topics, including but not limited to medical breakthroughs, healthy lifestyle tips, and updates on healthcare policies. We have developed a full business plan.GENERAL

~~Currently,~~Naploy weCorp. ~~have~~was noincorporated ~~employees,~~in ~~only~~the ~~our~~State ~~officers~~of Wyoming and ~~Directors~~established -on MrApril 6, 2023. ~~Frederick~~The ~~Sidney~~Company ~~Reinhard~~has ~~Arnold~~limited revenue and ~~Mr.~~incurred ~~Rafael~~losses ~~Angel~~since ~~Ulloa Bonilla~~inception. Our ~~executive~~primary ~~and~~focus ~~business office~~ is ~~located~~on atlaunching 95a ~~Lias~~news ~~Estate~~blog ~~Kafe~~that ~~district~~provides ~~Abuja~~the latest updates on health-related topics, ~~FCT~~including ~~900108~~but ~~Nigeria~~not limited to medical breakthroughs, healthy lifestyle tips, and ~~our~~updates ~~telephone~~on ~~number~~healthcare ispolicies. ~~+13072133163~~We have developed a full business plan.

~~The~~Currently, ~~COVID-19~~we ~~pandemic~~have ~~has~~no ~~had~~employees, aonly ~~significant~~our ~~impact~~officers ~~on the healthcare industry~~ and ~~has~~Directors ~~led~~- toMr. ~~changes~~Frederick inSidney ~~the~~Reinhard ~~way~~Arnold ~~healthcare~~and ~~services~~Mr. ~~are~~Rafael ~~delivered,~~Angel ~~including~~Ulloa ~~through~~Bonilla. ~~mobile~~Our ~~applications that~~executive ~~offer~~and ~~online~~business ~~information~~office ~~help~~is ~~services~~located at ~~for~~95 ~~finding~~Lias ~~medical~~Estate ~~institutions.~~Kafe ~~Here~~district ~~are~~Abuja, ~~some~~FCT ~~ways~~900108 ~~the~~Nigeria, ~~pandemic~~and ~~has~~our ~~affected~~telephone ~~these~~number ~~types of~~is ~~apps:~~+13072133163.

~~Increased demand:~~ The COVID-19 pandemic has ~~increased~~had ~~the~~a significant impact ~~demand~~on ~~for~~the healthcare ~~services,~~industry and ~~many~~has ~~people~~led ~~have~~to ~~turned~~changes toin the way healthcare services are delivered, including through mobile ~~apps~~applications that tooffer ~~find~~online information ~~about~~help services for finding medical institutions. ~~and~~Here ~~services.~~are some ways the pandemic has affected these types of apps:

~~Safety~~Increased ~~concerns~~demand: ~~Many~~The ~~people~~pandemic ~~are~~has ~~hesitant~~increased ~~to visit~~the ~~medical~~demand ~~institutions~~for inhealthcare ~~person~~services, ~~due~~and tomany ~~safety~~people ~~concerns,~~have ~~and~~turned to mobile apps ~~that~~to ~~offer~~find information about medical institutions and ~~their safety protocols can help alleviate these concerns~~services.

~~Our~~Safety ~~Naploy~~concerns: ~~App~~Many ispeople ~~your~~are ~~go-~~hesitant to ~~source for the latest~~visit ~~health~~medical ~~news~~institutions ~~and~~in ~~updates.~~person ~~Naploy~~due ~~App~~to ~~offers~~safety ~~an article library- News Blog that deals with the most common health topics. Our health blog covers diverse health related~~ concerns ~~such as nutrition and diet~~, ~~fitness, weight control, diseases, disease management, societal trends affecting health, analysis about health, business of health~~ and ~~health research. The app is available for both Android and iOS~~ mobile ~~operating~~ ~~systems~~apps ~~and~~that ~~provides~~offer ~~you~~information ~~with~~about ~~quick~~medical ~~access~~institutions ~~to a vast healthcare~~ and ~~medical~~their ~~database. With the " Naploy App," you~~safety protocols can ~~stay~~help ~~informed~~alleviate ~~about~~these ~~the latest health news anytime, anywhere~~concerns. ~~We are dedicated to bringing you high-quality health information and keeping you up-to-date on the latest developments in the world of healthcare.~~

~~One~~Our ofNaploy ~~our main~~ App ~~features~~ is ~~Symptom~~your ~~Diagnostic. Symptom~~go-to ~~Diagnostic~~source isfor anthe ~~advanced~~latest health ~~tool~~news ~~that~~and ~~uses high-grade AI technology to provide diagnoses~~updates. ~~Currently,~~Naploy ~~our~~App AIoffers ~~technology~~an isarticle ~~already working,~~library- ~~but~~News ~~during~~Blog ~~the~~that ~~lifetime~~deals ofwith the ~~APP~~most itcommon ~~should~~health ~~be refined and improved~~topics. ToOur ~~begin,~~health ~~you~~blog covers ~~will~~diverse ~~have~~health torelated ~~enter~~concerns ~~your~~such ~~age~~as nutrition and ~~gender~~diet, ~~after which~~fitness, ~~you~~weight ~~can~~control, ~~select~~diseases, ordisease ~~type~~management, insocietal ~~your~~trends affecting ~~symptoms~~health, ~~intensity~~analysis ~~and~~about ~~duration.~~health, ~~This~~business ~~step~~of ishealth ~~then~~and ~~followed~~health upresearch. byThe ~~some~~app ~~more~~is ~~questions~~available tofor ~~determine which~~both ~~symptom~~Android isand ~~bothering~~iOS ~~you~~mobile operating ~~the~~systems ~~most~~ and ifprovides you ~~are~~with onquick ~~meds~~access ~~and/or~~to ~~have~~a ~~had~~vast ~~any~~healthcare ~~conditions~~and inmedical ~~the past~~database. ~~Thereafter,~~With itthe ~~will~~" ~~give~~Naploy App," you acan ~~list~~stay ofinformed ~~possible~~about ~~conditions~~the ~~(about~~latest 5health news anytime, ~~starting~~anywhere. ~~with~~We ~~the~~are ~~most~~dedicated ~~likely)~~to ~~which~~bringing you ~~can~~high-quality ~~then~~health ~~click~~information on and keeping ~~find~~you ~~more~~up-to-date ~~details~~on ~~about~~the latest developments in the ~~disease~~world of healthcare.

~~Symptom~~One ~~Diagnostics~~of ~~are~~our anmain ~~innovative~~App ~~addition to~~features ~~digital~~is ~~health~~Symptom Diagnostic. Symptom ~~This~~Diagnostic is an advanced tool ~~does~~that ~~not~~uses high-grade AI technology to provide ~~medical~~diagnoses. ~~advice~~Currently, Itour AI technology is ~~intended~~already working, ~~for~~but ~~informational~~during ~~purposes~~the ~~only~~lifetime of the APP it should be refined and improved. ~~Nevertheless~~To begin, ~~these~~you ~~services~~will have to enter your age and gender, after ~~should~~which ~~not~~you becan ~~considered~~select asor ~~definite~~type ~~diagnostic~~in ~~tools~~your ~~but~~symptoms, ~~rather~~intensity asand aduration. ~~guide~~This tostep ~~point~~is ~~the~~then ~~user~~followed ~~towards~~up ~~possible~~by ~~conditions~~some ~~relating~~more questions to determine ~~their~~which ~~symptoms.~~symptom ~~Consulting~~is anbothering ~~actual~~you ~~physician~~the ~~will~~most ~~help~~and if you are on meds and/or have had any conditions in the past. Thereafter, it will give you a ~~more~~list ~~accurate~~of ~~diagnosis~~possible conditions (about 5, starting with the most likely) which you can then click on and ~~subsequent~~find ~~treatment~~more details about the disease.

13Symptom Diagnostics are an innovative addition to digital health. This tool does not provide medical advice It is intended for informational purposes only. Nevertheless, these services should not be considered as definite diagnostic tools but rather as a guide to point the user towards possible conditions relating to their symptoms. Consulting an actual physician will help you have a more accurate diagnosis and subsequent treatment.

For Naploy App and Symptom Diagnostic feature do not require regulatory approval in the United States, Nigeria or elsewhere because they provide information rather than direct medical advice. For the health app, despite providing useful functionalities, users are strongly encouraged to seek professional medical advice, especially when experiencing severe symptoms. The app’s features are intended for informational purposes only and must not replace the guidance of a medical professional in cases of severe symptoms or critical health concerns.

Our “Naploy App” includes a convenient Clinic Search feature that allows clients to contact us and send a request for searching the clinics and proper medical services that suit their needs for a fee. Through this feature, clients can request information about the type of treatment they need, as well as leave their phone number and email. Our team will then contact the client to clarify all the necessary details about their diagnosis and treatment needs. Our expert managers will then provide information about the best medical institutions for the client, including details about the location, clinic licenses, doctors, we will monitor all the reviews and feedbacks and check all the doctors for their professional qualifications. Our clients can expect top-notch customer service, as our managers will communicate with them through phone, email, and messengers according to their preferences. We are dedicated to providing the professional services in searching the best medical institutions, making for the right medical care for our clients. We will make this process much easier and comfortable for clients from our professional website.12

InOur ~~addition~~“Naploy App” includes a convenient Clinic Search feature that allows clients to contact us and send a request for searching the clinics and proper medical services that suit their needs for a fee. Through this feature, clients can request information about the type of treatment they need, as well as leave their phone number and email. Our team will then contact the client to clarify all the necessary details about their diagnosis and treatment needs. Our expert managers will then provide information about the best medical institutions for the client, including details about the location, clinic licenses, doctors, we ~~also~~will ~~offer~~monitor ~~paid~~all ~~contextual~~the ~~advertising~~reviews and feedbacks and check all the doctors for their professional qualifications. Our clients can expect top-notch customer service, as our managers will communicate with them through phone, email, and messengers according to their preferences. We are dedicated to providing the professional services ~~for~~in searching the best medical institutions, onmaking for the right medical care for our ~~Naploy~~clients. ~~app’s~~We ~~news~~will ~~blog:~~make this process much easier and comfortable for clients from our professional website.

~~–Banner~~In ~~ads~~addition, we also offer paid contextual advertising services for medical institutions on our Naploy app’s news blog:

~~Our banner advertising will consist of static or animated images or media and would be placed in high-visibility areas.~~ –Banner ~~advertising is attractive because it can help create medical institutions awareness and generate leads.~~ads

~~–Pop~~Our upbanner advertising will consist of static or animated images or media and would be placed in high-visibility areas. Banner advertising is attractive because it can help create medical institutions awareness and generate leads.

~~Another~~–Pop ~~effective form of our advertising services. Unlike banner ads, the pop-~~up ~~will appear in the center of the screen, drawing the attention of customers.~~

ByAnother ~~utilizing~~effective form of our advertising services~~, medical institutions can increase their online presence and reach a wider audience~~. ~~Our goal is to provide a comprehensive platform for both health~~ ~~news~~Unlike ~~and~~banner ~~healthcare advertising~~ads, ~~and~~the wepop-up ~~believe that this additional feature~~ will beappear ain ~~valuable~~the ~~asset~~center ~~for~~of ~~both~~the ~~our~~screen, ~~users~~drawing ~~and~~the ~~medical~~attention ~~institutions~~of customers.

WeBy ~~are~~utilizing ~~offering~~ our advertising services, medical institutions can increase their online presence and reach a wider audience. Our goal is to ~~the~~provide ~~clients~~a incomprehensive platform for both health ~~Nigeria~~news and ~~then~~healthcare advertising, and we ~~are~~believe ~~going~~that tothis ~~spread~~additional ~~our~~feature ~~services~~will inbe ~~other~~a ~~African~~valuable ~~countries~~asset for both our users and medical institutions.

We ~~have~~are ~~purchased~~offering our services to the ~~mobile~~clients ~~application~~in Nigeria and ~~website for~~then ~~iOS~~we ~~and~~are ~~Android~~going ~~platforms~~to ~~for~~spread ~~total~~our ~~consideration~~services ofin USother ~~$45,000~~African countries.

~~Here~~We ~~are~~have ~~some~~purchased of the ~~technologies~~mobile ~~that~~application weand ~~intend~~website ~~successfully~~for toiOS ~~implement~~and inAndroid ~~our~~platforms ~~mobile~~for ~~application:~~total consideration of US $45,000.

–Here ~~Improvement~~are some of the AItechnologies ~~technology~~that we intend successfully to implement in our mobile application:

– ~~Map~~Improvement ~~View~~of the AI technology

– ~~Reviews~~Map View

– ~~Booking Services~~Reviews

– ~~Notifications~~Booking Services

– ~~Marketing Opportunities~~Notifications

– ~~Body~~Marketing ~~map symptom checker~~Opportunities

– ~~Personal~~Body ~~health~~map ~~tracker~~symptom checker

– ~~Medicine~~Personal ~~reminder~~health tracker

– ~~Language~~Medicine ~~translation~~reminder

14– Language translation

Our “Naploy App” is regularly updated with articles written by healthcare professionals and industry experts, ensuring that our clients have access to high-quality and reliable health information. The content provided on our app is primarily sourced from reputable open channels, ensuring credibility and accuracy. In addition to open sources, we curate content from trusted platforms such as https://medicalxpress.com/. All news stories are hand-processed and curated by qualified editors on https://medicalxpress.com/, obviating the problems of feed or bot aggregation. This ensures that high-quality, targeted sci-tech news stories are published on website. It’s pertinent to highlight that we do not engage in content licensing agreements as we are utilizing the information from reliable open sources and ensure that our users receive high-quality, updated, and relevant health information through the Naploy app. We believe that our app will not only keep our clients informed but also empower them to take control of their health and make informed decisions about their wellbeing. All our features make our mobile application a comprehensive resource for clients seeking reliable and relevant health information. We intend continuously make improvements, maintenances and expand of our application as well as develop complementary products and services for our consumers. In addition, within two-three years after the success of the Nigerian market, we intend to popularize the application to other African countries, starting with neighboring Benin, Chad, Cameroon and Niger. Furthermore, potential target countries for expansion could encompass regions such as Kenya, South Africa, and Ethiopia. The company intends to evaluate the market readiness and demand within these countries and strategically expand its services to cater to these regions, ensuring the compatibility of the online health platform with the local healthcare landscapes and technological infrastructure.

~~OUR MOBILE APPLICATION AND THE PROCESS~~13

~~Currently,~~OUR weMOBILE ~~have~~APPLICATION aAND ~~mobile~~THE ~~application for Android and iOS platforms known as “Naploy App”. Links for the application:~~PROCESS

~~https://play~~Currently, we have a mobile application for Android and iOS platforms known as “Naploy App”.~~google.com/store/apps/details?id=naploy.app&hl=uk&gl=US~~ Links for the application:

https://~~apps~~play.~~apple~~google.com/usstore/~~app~~apps/details?id=naploy~~/id6451121811~~.app&hl=uk&gl=US

~~Our application is completely operational and ready for use, enabling customers to access and acquire our company’s services~~https://apps. ~~However, we plan to further develop and expand the application’s functionality by integrating new and beneficial features and systems that will enhance the experience for our potential customers~~apple.com/us/app/naploy/id6451121811.

~~The~~Our ~~Naploy~~application ~~app~~is ~~was~~completely ~~officially~~operational ~~launched~~and ready onfor ~~the Apple~~use, ~~Store~~enabling ~~and~~customers ~~Play~~to ~~Store~~access onand ~~July~~acquire ~~24,~~our ~~2023~~company’s services. ~~To date~~However, we ~~have~~plan ~~more~~to ~~than~~further 10develop ~~active~~and ~~users.~~expand ~~We don~~the application’ts ~~have~~functionality ~~any~~by ~~clients~~integrating new and beneficial features and systems that will enhance the experience for ~~advertising~~our potential ~~yet~~customers.

The ~~main~~Naploy ~~functionality~~app ~~features~~was ~~and~~officially ~~opportunities~~launched on the ofApple ~~currently~~Store ~~application~~and ~~with~~Play ~~the~~Store ~~app~~on ~~and~~July ~~website~~24, ~~content~~2023. ~~are:~~To date, we have more than 10 active users. We don’t have any clients for advertising yet.

~~News~~The ~~Blog~~main functionality features and opportunities of currently application with the app and website content are:

~~– After entering the app, the person can access our~~ News blog, which covers diverse health-related concerns such as nutrition and diet, fitness, weight control, diseases, disease management, societal trends affecting health, analysis about health, business of health, and health research. Now this feature is already implemented in our app and the website, with the content provided from reputable open channels, ensuring credibility and accuracy. In addition to open sources, we curate content from trusted platforms such as httpsBlog:~~//medicalxpress.com/.~~

~~Symptom~~– ~~Diagnostic~~After entering the app, the person can access our News blog, which covers diverse health-related concerns such as nutrition and diet, fitness, weight control, diseases, disease management, societal trends affecting health, analysis about health, business of health, and health research. Now this feature is already implemented in our app and the website, with the content provided from reputable open channels, ensuring credibility and accuracy. In addition to open sources, we curate content from trusted platforms such as https://medicalxpress.com/.

~~– The person can use our advanced~~ Symptom Diagnostic tool, which uses high-grade AI technology to provide diagnoses. – They have to enter their age and gender, select or type in their symptoms, intensity and duration, and answer some follow-up questions about their medical history and current condition. – Based on the information provided, Symptom Diagnostic will give them a list of possible conditions (about 5, starting with the most likely), which they can click on to find more details about the disease.:

~~This~~– ~~feature~~The isperson ~~fully~~can ~~functional~~use in our ~~app~~advanced ~~and the~~Symptom ~~website~~Diagnostic ~~but~~tool, ~~users~~which ~~are~~uses ~~strongly~~high-grade ~~encouraged~~AI technology to ~~seek~~provide ~~professional~~diagnoses. ~~medical~~– ~~advice~~They have to enter their age and gender, ~~especially~~select ~~when~~or ~~experiencing~~type ~~severe~~in their symptoms., ~~The~~intensity ~~app’s features~~and ~~are~~duration, ~~intended~~and ~~for~~answer ~~informational~~some ~~purposes~~follow-up ~~only~~questions about their medical history and ~~must~~current ~~not~~condition. ~~replace~~– Based on the ~~guidance~~information ofprovided, aSymptom ~~medical~~Diagnostic ~~professional~~will ingive ~~cases~~them a list of ~~severe~~possible ~~symptoms or~~conditions ~~critical~~(about ~~health~~5, ~~concerns~~starting with the most likely), which they can click on to find more details about the disease.

15This feature is fully functional in our app and the website but users are strongly encouraged to seek professional medical advice, especially when experiencing severe symptoms. The app’s features are intended for informational purposes only and must not replace the guidance of a medical professional in cases of severe symptoms or critical health concerns.

Clinic Search:

	–	Contact us: The client sends a request to our team through the Clinic Search feature on our "Naploy App" stating the type of treatment they need and leaves their name, phone number, email and location.
	–	Clarification: Our team contacts the client to clarify all the necessary details about their diagnosis and treatment needs.
	–	Search: Our expert managers search for the best medical institutions that suit the client’s needs, including details about the location, clinic licenses, doctors, and ratings of medical institutions for a fee.
	–	Quality Check: We monitor all the reviews and feedback and check all the doctors for their professional qualifications to ensure that we only recommend the best medical institutions.
	–	Communication: Our managers communicate with clients through phone, email, and messengers according to their preferences to provide top-notch customer service.
	–	Recommendations: Our managers provide information about the top 5 medical institutions that suit the client’s needs and preferences.
	–	Follow-up: We follow up with clients to ensure that they are satisfied with the recommended medical institution and if any further assistance is needed.
	–	Convenience: We ensure that the whole process is comfortable and easy for clients through our professional website and mobile application.

To date our directors interact with our potential customers, but we don’t have any clients for our clinic search services yet. We are going to hire freelance managers once we have our first client and establish our initial client base. We intend to engage with these managers by formalizing freelance agreements.

~~Here are some of the technologies that we intend successfully to implement in our mobile application (during 1-18 months):~~14

–Here Improvement of the implemented AI technology: The app will provide Implemented AI technology that is in the process of being fully implemented, revision and will undergo continuous refinement and improvement to ensure the highest level of performance. – Map View: The app will provide a map view that enables clients to view medical institutions on a map and get directions to the chosen location. – Reviews: The app will provide a review section where clients can read reviews of medical institutions left by other users and leave their own reviews. – Booking Services: The app will provide booking services, allowing clients to book appointments with medical professionals or reserve hospital rooms. – Notifications: The app will send notifications to clients regarding new medical institutions added to the database or promotions and deals available at certain institutions. – Marketing Opportunities: The app will offer marketing opportunities for medical institutions, including sponsored listings and targeted advertising. – Body map symptom checker: This functionality allows users to select the specific area of their body where they are ~~experiencing~~some ~~symptoms and then select the symptoms, they are experiencing from a list~~ of options associated with that area. – Personal health tracker: This feature can help users track their personal health by allowing them to input their health data such as blood pressure, blood sugar, and weight, and keep track of their progress over time. Users can set health goals, receive notifications, and view progress reports. – Medicine reminder: The app can also feature a medicine reminder that helps users keep track of their medication schedules. Users can set reminders for when to take their medications and the ~~app~~technologies ~~will send notifications accordingly. – Language translation: The app can also integrate a language translation feature~~ that ~~allows~~we ~~users~~intend successfully to ~~translate~~implement ~~medical~~in ~~terms,~~our ~~instructions,~~mobile ~~and~~application ~~prescriptions~~(during ~~into~~1-18 ~~their preferred language.~~months):

16– Improvement of the implemented AI technology: The app will provide Implemented AI technology that is in the process of being fully implemented, revision and will undergo continuous refinement and improvement to ensure the highest level of performance. – Map View: The app will provide a map view that enables clients to view medical institutions on a map and get directions to the chosen location. – Reviews: The app will provide a review section where clients can read reviews of medical institutions left by other users and leave their own reviews. – Booking Services: The app will provide booking services, allowing clients to book appointments with medical professionals or reserve hospital rooms. – Notifications: The app will send notifications to clients regarding new medical institutions added to the database or promotions and deals available at certain institutions. – Marketing Opportunities: The app will offer marketing opportunities for medical institutions, including sponsored listings and targeted advertising. – Body map symptom checker: This functionality allows users to select the specific area of their body where they are experiencing symptoms and then select the symptoms, they are experiencing from a list of options associated with that area. – Personal health tracker: This feature can help users track their personal health by allowing them to input their health data such as blood pressure, blood sugar, and weight, and keep track of their progress over time. Users can set health goals, receive notifications, and view progress reports. – Medicine reminder: The app can also feature a medicine reminder that helps users keep track of their medication schedules. Users can set reminders for when to take their medications and the app will send notifications accordingly. – Language translation: The app can also integrate a language translation feature that allows users to translate medical terms, instructions, and prescriptions into their preferred language.

REVENUE

Advertising: The app can feature advertisements from medical institutions, pharmaceutical companies, or other related businesses. The fee for in-app ads can vary based on the size and placement of the ad.

We offer such paid contextual advertising services:

– Banner ads

Our banner advertising will consist of static or animated images or media and would be placed in high-visibility areas. Banner advertising is attractive because it can help create medical institutions awareness and generate leads.

– Pop up

Another effective form of our advertising services. Unlike banner ads, the pop-up will appear in the center of the screen, drawing the attention of customers.

Clinic Search: Clients will be charged a fee for using our Clinic Search feature to find the best medical institutions that suit their needs. The fee will vary depending on the complexity of the search and the level of support required from our team.

In future the additional source of revenue could be through other services:

Subscription Model: We will offer a subscription model for clients who need ongoing support from our team in finding medical institutions for their specific needs. The subscription fee will provide access to our team’s expertise and support.

Referral fees: The app can earn referral fees from medical institutions for each new patient that the app directs to them. This could include fees for booking appointments or fees for any services provided by the medical institution. The prices for referral fees can vary depending on the type of service provided and the level of commission offered.15

AsReferral offees: ~~the~~The ~~current~~app ~~date,~~can ~~Naploy~~earn ~~Corp. does not~~referral ~~have~~fees ~~any~~from ~~material~~medical ~~contracts~~institutions orfor ~~letters~~each ofnew ~~intent~~patient ~~with~~that ~~medical~~the ~~institutions~~app ~~for~~directs ~~referral~~to ~~arrangements~~them. ~~The~~This ~~revenue~~could ~~model~~include ~~relies~~fees onfor ~~potential~~booking appointments or ~~future~~fees ~~collaborations~~for ~~with~~any services provided by the medical ~~institutions,~~institution. ~~and~~The weprices ~~will~~for ~~ensure~~referral ~~that~~fees ~~any~~can ~~such~~vary ~~agreements~~depending ~~comply~~on ~~with~~the ~~regulatory~~type ~~requirements~~of service provided and the level of commission offered.

~~It’s~~As ~~important~~of tothe ~~note~~current ~~that~~date, atNaploy ~~present, there~~Corp. ~~are~~does ~~no regulatory implications to address as we~~ not have ~~not~~any ~~yet~~material ~~engaged~~contracts inor ~~formal~~letters ~~agreements~~of intent with medical institutions for referral ~~fees~~ arrangements. ~~Any~~The ~~future~~revenue ~~collaborations~~model ~~will~~relies beon ~~approached~~potential future collaborations with ~~careful~~medical ~~consideration~~institutions, ofand ~~regulatory~~we ~~compliance~~will to ensure ~~transparency~~that ~~and~~any ~~adherence to~~such ~~applicable~~agreements ~~standards~~comply with regulatory requirements.

~~Data~~It’s ~~analytics:~~important ~~The~~to ~~app~~note ~~can~~that, ~~collect~~at ~~and~~present, ~~analyze~~there ~~user~~are ~~data~~no toregulatory ~~provide~~implications ~~insights~~ to ~~healthcare~~address ~~providers~~as ~~and~~we ~~researchers.~~have ~~This~~not ~~could~~yet ~~include~~engaged ~~anonymized~~in ~~data~~formal onagreements ~~user~~with ~~demographics,~~ medical ~~conditions,~~institutions ~~and~~for ~~treatment outcomes~~referral fees. ~~The~~Any ~~app~~future ~~can~~collaborations ~~charge~~will ~~fees~~be toapproached ~~healthcare~~with ~~providers~~careful ~~and~~consideration ~~researchers~~of ~~for~~regulatory ~~access~~compliance to ~~this~~ensure ~~data.~~transparency ~~The prices for data analytics can vary depending on the level of access~~ and ~~the~~adherence to ~~type~~applicable ~~of data provided~~standards.

üData ~~Prices~~analytics: The app can collect and analyze user data to provide insights to healthcare providers and researchers. This could include anonymized data on user demographics, medical conditions, and treatment outcomes. The app can charge fees to healthcare providers and researchers for ~~Services:~~access to this data. The prices for data analytics can vary depending on the level of access and the type of data provided.

~~Advertising:~~ü ~~$0.50-$1.00~~Prices ~~per~~for ~~click or monthly advertising $150-$1,000.~~Services:

~~Clinic Search~~Advertising: ~~Starting at~~ $0.50-$~~500~~1.00 per ~~search, prices~~click ~~will~~or ~~vary~~monthly advertising ~~based on the complexity of the search and level of support required~~$150-$1,000.

üClinic ~~Prices~~Search: ~~for~~Starting ~~Services~~at in$50-$500 ~~future:~~per search, prices will vary based on the complexity of the search and level of support required.

~~Subscription~~ü ~~Model:~~Prices ~~Starting~~for ~~from~~Services ~~$70~~in ~~per month, prices will vary based on the level of support required.~~future:

~~Referral~~Subscription ~~fees~~Model: ~~5%-15%~~Starting offrom ~~the~~$70 ~~total~~per ~~cost~~month, prices will vary based on the level of ~~service~~support required.

~~Data~~Referral ~~analytics~~fees: ~~$200~~5%-~~$2,000~~15% ~~per~~of ~~report, depending on~~ the ~~level~~total cost of ~~detail and analysis provided~~service.

~~The~~Data ~~“Prices~~analytics: ~~for Services” and “Prices for Services in the future” are based on estimated ranges derived from market research~~$200-$2,000 ~~industry~~per ~~benchmarks~~report, ~~and an assessment of~~depending ~~the value provided by our services. These figures are not static and may be subject to change based~~ on ~~various~~the ~~factors,~~level ~~including~~of ~~market conditions,~~detail ~~service enhancements,~~ and ~~feedback~~analysis ~~from clients~~provided.

17The “Prices for Services” and “Prices for Services in the future” are based on estimated ranges derived from market research, industry benchmarks, and an assessment of the value provided by our services. These figures are not static and may be subject to change based on various factors, including market conditions, service enhancements, and feedback from clients.

COMPETITION

The health app market is highly competitive, with many established players and new entrants vying for a share of the market. Some of the major competitors in the field of health apps include Zocdoc, Healthgrades, and WebMD.

In addition to these major players, there are many other health apps on the market that offer a variety of features. As the demand for health-related apps continues to grow, the competition in this space is likely to remain fierce.

Through our marketing strategy and continuous development of new features, we believe that our mobile app can succeed in the health market.

MARKETING

Marketing and sales strategy are crucial components for the success of any business, including mobile applications. In order to ensure the success of our online health platform, we plan to implement a multi-faceted marketing and sales strategy.

– Digital Marketing:

We will use various digital marketing techniques to reach our target audience, including search engine optimization (SEO), pay-per-click (PPC) advertising, social media marketing, and email marketing. We will use relevant keywords and phrases to optimize our app’s visibility on search engines and social media platforms. We will also use targeted email marketing campaigns to promote our app to potential users.

~~– Content Marketing:~~16

We– ~~will~~Content develop a content marketing strategy that focuses on creating valuable and informative content related to healthcare, medical institutions, and related topics. This content will be published on our website and social media platforms, and shared with relevant online communities and groups.Marketing:

–We ~~Influencer~~will ~~Marketing:~~develop a content marketing strategy that focuses on creating valuable and informative content related to healthcare, medical institutions, and related topics. This content will be published on our website and social media platforms, and shared with relevant online communities and groups.

We– ~~will~~Influencer work with healthcare influencers and bloggers to promote our app and reach a wider audience. We will collaborate with influencers to develop content related to our app and its features and encourage them to share their experiences with our app with their followers.Marketing:

–We ~~Partnering~~will work with ~~Medical~~healthcare ~~Institutions:~~influencers and bloggers to promote our app and reach a wider audience. We will collaborate with influencers to develop content related to our app and its features and encourage them to share their experiences with our app with their followers.

We– ~~will~~Partnering ~~partner in future~~ with ~~medical~~Medical ~~institutions such as hospitals, clinics, and healthcare centers to promote our app to their patients.~~Institutions:

–We Towill ~~invite~~partner ~~new~~in ~~clients~~future ~~via~~with ~~word-of-mouth~~medical institutions ~~referrals~~such as hospitals, clinics, and healthcare centers to promote our app to their patients.

– To ~~place~~invite ~~outdoor~~new ~~display~~clients ~~advertisements in~~via ~~public transportation terminals and residential complexes in selected cities~~word-of-mouth referrals.

We– ~~are~~To ~~going~~place tooutdoor ~~spend~~display ~~some part of proceeds on~~advertisements ~~the~~in ~~development~~public oftransportation ~~our~~terminals ~~website~~ and ~~mobile~~residential ~~application~~complexes ~~and extension of functionality~~ in ~~order~~selected ~~to attract more potential customers and to make our services more desirable~~cities.

~~EMPLOYEES~~We are going to spend some part of proceeds on the development of our website and mobile application and extension of functionality in order to attract more potential customers and to make our services more desirable.

~~We are a development stage company and currently have no employees, other than our officers, Mr. Arnold and Mr. Ulloa Bonilla.~~EMPLOYEES

18We are a development stage company and currently have no employees, other than our officers, Mr. Arnold and Mr. Ulloa Bonilla.

OFFICES

Our corporate headquarters is located at 95 Lias Estate Kafe district Abuja, FCT 900108 Nigeria and our phone number is +13072133163. Further, this space has been provided by our executives Mr. Frederick Sidney Reinhard Arnold and Mr. Rafael Angel Ulloa Bonilla free of cost. We consider our current principal office space arrangement adequate and will reassess our needs based upon the future growth of the company. Further, this space has been provided by our executives Mr. Frederick Sidney Reinhard Arnold and Mr. Rafael Angel Ulloa Bonilla for free.

PATENTS AND TRADEMARK

Currently, we do not own, either legally or beneficially, any patents or trademarks.

GOVERNMENT REGULATION

We will be the subject to applicable laws and regulations that relate directly or indirectly to our operations including United States and Nigeria securities laws. These laws, regulations, and standards govern issues such as worker classification, labor and employment, anti-discrimination, payments, worker confidentiality obligations, product liability, environmental protection, personal injury, text messaging, subscription services, intellectual property, consumer protection and warnings, marketing, taxation, privacy, data security, competition, unionizing and collective action, arbitration agreements and class action waiver provisions, terms of service, mobile application and website accessibility, money transmittal, and background checks. We will be required to comply with all regulations, rules and directives of governmental authorities and agencies applicable to our services in Nigeria and to operation of any facility in any jurisdiction which we would conduct activities.

The healthcare industry in USA are regulated at both the state and federal levels. Our ability to operate profitably will depend in part upon our ability to maintain all necessary licenses if required and to operate in compliance with applicable laws and rules. Those laws and rules continue to evolve. As the applicable laws and rules change, we are likely to make conforming modifications in our business processes from time to time.

Operating in Nigeria involves navigating a distinct regulatory landscape. The National Health Act, Companies and Allied Matters Act (CAMA), and the Nigerian Data Protection Regulation (NDPR) are pivotal legal frameworks shaping our healthcare and technology-related services. Ensuring compliance with these laws underscores our commitment to local regulations, covering areas such as healthcare service delivery, corporate governance, and data protection.17

~~Currently~~Operating wein ~~are~~Nigeria ininvolves ~~compliance~~navigating ~~with~~a ~~applicable~~distinct ~~regulations~~regulatory inlandscape. ~~Nigeria~~The National Health Act, ~~including~~Companies and Allied Matters Act (CAMA), and the Nigerian Data Protection Regulation. We(NDPR) are ~~believe~~pivotal ~~that~~legal ~~government~~frameworks ~~regulation~~shaping ~~will~~our ~~have~~healthcare noand ~~material impact~~technology-related onservices. ~~the~~Ensuring ~~way~~compliance wewith ~~conduct~~these laws underscores our commitment ~~business~~to local regulations, covering areas such as healthcare service delivery, corporate governance, and data protection.

~~LEGAL~~Currently ~~PROCEEDINGS~~we are in compliance with applicable regulations in Nigeria, including the Nigerian Data Protection Regulation. We believe that government regulation will have no material impact on the way we conduct our business.

WeLEGAL ~~are not involved in any pending legal proceeding nor are we aware of any pending or threatened litigation against us.~~PROCEEDINGS

19We are not involved in any pending legal proceeding nor are we aware of any pending or threatened litigation against us.

RESULTS OF OPERATIONS

For three months ended ~~October~~January 31, ~~2024~~2025 and ~~2023~~2024

During the three months ended ~~October~~January 31, ~~2024~~2025 and ~~2023~~2024, we generated $~~581~~2,139 and $0 of revenue, respectively. The increase in revenue was due to start of sales of our services in October 2024.

Total expenses for the three months ended ~~October~~January 31, ~~2024~~2025 and ~~2023~~2024, were $105,~~642~~568 and $36,~~033~~019, respectively, which were comprised of ~~depreciation~~amortization expense ($2,250 as of ~~October~~January 31, ~~2024 and~~2025 and $2,250 as of ~~October~~January 31, ~~2023~~2024); general and administrative fees of the Company ($2724 as of ~~October~~January 31, ~~2024~~2025 and $331 as of ~~October~~January 31, ~~2023~~ 2024); and professional fees ($83,~~365~~294 as of ~~October~~January 31, ~~2024~~2025 and $~~750~~3,768 as of ~~October~~January 31, ~~2023~~2024).

The Company recorded a net loss of $103,~~061~~429 and $36,~~033~~019 for the three months ended ~~October~~January 31, ~~2024~~2025 and ~~2023~~2024, respectively.

~~LIQUIDITY~~For ~~AND~~six ~~CAPITAL~~months ~~RESOURCES~~ended January 31, 2025 and 2024

AsDuring ofthe ~~October~~six months ended January 31, 2025 and 2024, ~~our~~we ~~total~~generated ~~assets~~$2,719 ~~were~~ and $610 of revenue,~~103~~ respectively. ~~Total~~The ~~assets~~increase ~~were~~in ~~comprised~~revenue ofwas ~~$27,728~~due into ~~current~~start ~~assets~~of ~~and~~sales ~~$33,375~~of inour ~~intangible~~services ~~assets~~in October 2024.

AsTotal ofexpenses ~~October~~for the six months ended January 31, 2024 and 2023, ~~our~~were ~~current~~$16,209 ~~liabilities~~ and $9,052, respectively, which were comprised of amortization expense ($614,~~578~~500 as of January 31, 2025 and ~~Stockholders’~~$4,500 ~~deficit~~as ~~was~~of January 31, 2024); general and administrative fees of the Company ($~~475~~50 as of January 31, 2025 and $34 as of January 31, 2024); and professional fees ($11,659 as of January 31, 2025 and $4,518 as of January 31, 2024).

~~CASH~~The ~~FLOWS~~Company ~~FROM~~recorded ~~OPERATING~~a ~~ACTIVITIES~~net loss of $13,490 and $9,052 for the six months ended January 31, 2025 and 2024, respectively.

~~For~~LIQUIDITY ~~the~~AND ~~three~~CAPITAL ~~months ended October 31, 2024, net cash flows used in operating activities was $(5,992).~~RESOURCES

~~CASH~~As ~~FLOWS~~of ~~FROM~~January ~~INVESTING~~31, ~~ACTIVITIES~~2025, our total assets were $58,599. Total assets were comprised of $27,474 in current assets and $31,125 in intangible assets.

~~For~~As ~~the~~of ~~three~~January ~~months ended October~~ 31, ~~2024~~2025, weour ~~have~~current ~~not~~liabilities were ~~generated~~$62,503 ~~any~~and ~~cash~~Stockholders’ ~~flows~~deficit ~~from~~was ~~investing activities~~$3,904.

CASH FLOWS FROM ~~FINANCING~~OPERATING ACTIVITIES

For the ~~three~~six months ended ~~October~~January 31, ~~2024~~2025, net cash flows ~~provided~~used byin ~~financing~~operating activities was $1(6,~~375~~309).

~~Since~~CASH ~~inception,~~FLOWS weFROM ~~have~~INVESTING sold 2,000,000 shares of our common stock to our officer and director Frederick Sidney Reinhard Arnold at a price of $0.0001 per share, for aggregate proceeds of $200, and 1,803,370 shares to our shareholders at a price of $0.02 per share, for aggregate proceeds of $36,067.ACTIVITIES

~~Our~~For ~~auditors have issued a “going concern” opinion, meaning that there is substantial doubt if we can continue as an on-going business for~~ the ~~next~~six ~~twelve~~ months ~~unless we obtain~~ended ~~additional~~January ~~capital.~~31, No2025, ~~substantial revenues are anticipated until~~ we have ~~completed~~not ~~the~~generated ~~financing~~any ~~from this offering and implemented our plan of operations. Our only source for~~ cash atflows ~~this~~from ~~time~~investing ~~is investments by others in this offering~~activities. We must raise cash to implement our strategy and stay in business. The amount of the offering will likely allow us to operate for at least one year and have the capital resources required to cover the material costs with becoming a publicly reporting. The company anticipates over the next 12 months the cost of being a reporting public company will be approximately $15,000.

20CASH FLOWS FROM FINANCING ACTIVITIES

WeFor ~~cannot guarantee that we will be able to sell all~~ the ~~shares~~six ~~offered~~months ~~herein.~~ended IfJanuary we31, ~~are successful~~2025, ~~any money raised will be applied to the items set forth in the Use of Proceeds section~~net ofcash ~~this~~flows ~~Prospectus.~~provided Weby ~~will~~financing ~~attempt~~activities towas ~~raise the necessary funds to proceed with all phases of our plan of operation. The sources of funding we may consider to fund this work include a public offering~~$1, ~~a private placement of our securities or loans from our directors or others~~438.

As of the date of this Form 10-Q, the current funds available to us are not sufficient to implement our business plan until we raise funds from this offering. In case we need additional financing, our Mr. Ulloa Bonilla agreed to loan us funds to implement our business plan.18

~~OFF-BALANCE~~Since ~~SHEET~~inception, ~~ARRANGEMENTS~~we have sold 2,000,000 shares of our common stock to our officer and director Frederick Sidney Reinhard Arnold at a price of $0.0001 per share, for aggregate proceeds of $200, and 1,803,370 shares to our shareholders at a price of $0.02 per share, for aggregate proceeds of $36,067.

WeOur auditors have noissued ~~off-balance~~a ~~sheet~~“going ~~arrangements~~concern” opinion, meaning that ~~have~~there oris ~~are~~substantial ~~reasonably~~doubt if we can continue as an on-going business for the next twelve months unless we obtain ~~likely~~additional tocapital. No substantial revenues are anticipated until we have acompleted ~~current~~the orfinancing ~~future~~from ~~effect~~this onoffering and implemented our plan ~~financial~~of ~~condition,~~operations. ~~changes~~Our only source for cash at this time is investments by others in ~~financial~~this ~~condition,~~offering. ~~revenues~~We ormust ~~expenses,~~raise ~~results~~cash ofto implement our ~~operations,~~strategy ~~liquidity,~~and ~~capital~~stay ~~expenditures~~in orbusiness. The amount of the offering will likely allow us to operate for at least one year and have the capital resources required to cover the material costs with becoming a publicly reporting. The company anticipates over the next 12 months the cost of being a reporting public company will be approximately $15,000.

~~ITEM~~We 3cannot guarantee that we will be able to sell all the shares offered herein. ~~QUANTITATIVE~~If ~~AND~~we ~~QUALITATIVE~~are ~~DISCLOSURES~~successful, ~~ABOUT~~any ~~MARKET~~money ~~RISK~~raised will be applied to the items set forth in the Use of Proceeds section of this Prospectus. We will attempt to raise the necessary funds to proceed with all phases of our plan of operation. The sources of funding we may consider to fund this work include a public offering, a private placement of our securities or loans from our directors or others.

~~None~~As of the date of this Form 10-Q, the current funds available to us are not sufficient to implement our business plan until we raise funds from this offering. In case we need additional financing, our Mr. Ulloa Bonilla agreed to loan us funds to implement our business plan.

~~ITEM~~OFF-BALANCE 4.SHEET ~~CONTROLS AND PROCEDURES~~ARRANGEMENTS

~~Our~~We ~~management~~have isno ~~responsible for establishing and maintaining a system of disclosure controls and procedures (as defined in Rule 13a~~off-~~15(e)~~balance ~~and~~sheet ~~15d-15(e)~~arrangements ~~under~~that ~~the~~have ~~Exchange~~or ~~Act)~~are ~~that~~reasonably islikely ~~designed~~ to ~~ensure~~have ~~that~~a ~~information~~current ~~required to be disclosed by us in the reports that we file~~ or ~~submit~~future ~~under~~effect ~~the~~on ~~Exchange~~our ~~Act~~financial ~~is recorded~~condition, ~~processed,~~changes ~~summarized and reported, within the time periods specified~~ in ~~the~~financial ~~Commission’s rules and forms. Disclosure controls and procedures include~~condition, ~~without~~revenues ~~limitation, controls and procedures designed to ensure that information required to be disclosed by an issuer in the reports that it files~~ or ~~submits under the Exchange Act is accumulated and communicated to the issuer’s management~~expenses, ~~including~~ ~~its~~results ~~principal executive officer or officers and principal financial officer or officers~~of operations, ~~or persons performing similar functions~~liquidity, as ~~appropriate~~capital toexpenditures ~~allow~~or ~~timely~~capital ~~decisions regarding required disclosure~~resources.

AnItem evaluation was conducted under the supervision and with the participation of our management of the effectiveness of the design and operation of our disclosure controls and procedures as of October 31, 20243. ~~Based~~Quantitative ~~on that evaluation, our management concluded that our disclosure controls~~ and ~~procedures~~Qualitative ~~were~~Disclosures ~~not~~About ~~effective as~~Market of such date to ensure that information required to be disclosed in the reports that we file or submit under the Exchange Act, is recorded, processed, summarized and reported within the time periods specified in SEC rules and forms.Risk

~~Changes in Internal Controls over Financial Reporting~~None.

~~There~~Item ~~was~~4. noControls ~~change~~and in the Company’s internal control over financial reporting during the quarterly period covered by this report that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting.Procedures

21Our management is responsible for establishing and maintaining a system of disclosure controls and procedures (as defined in Rule 13a-15(e) and 15d-15(e) under the Exchange Act) that is designed to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the Commission’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by an issuer in the reports that it files or submits under the Exchange Act is accumulated and communicated to the issuer’s management, including its principal executive officer or officers and principal financial officer or officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.

~~PART~~An IIevaluation was conducted under the supervision and with the participation of our management of the effectiveness of the design and operation of our disclosure controls and procedures as of January 31, 2025. ~~OTHER~~Based ~~INFORMATION~~on that evaluation, our management concluded that our disclosure controls and procedures were not effective as of such date to ensure that information required to be disclosed in the reports that we file or submit under the Exchange Act, is recorded, processed, summarized and reported within the time periods specified in SEC rules and forms.

~~ITEM~~Changes 1.in ~~LEGAL~~Internal ~~PROCEEDINGS~~Controls over Financial Reporting

There ~~are~~was no ~~pending~~change ~~legal~~in ~~proceedings to which~~ the Company’s isinternal control aover ~~party~~financial orreporting induring ~~which any director, officer or affiliate of~~ the ~~Company,~~quarterly ~~any~~period ~~owner~~covered ofby ~~record~~this orreport ~~beneficially~~that ofhas ~~more~~materially ~~than 5% of any class of voting securities of the Company~~affected, or ~~security holder~~ is areasonably ~~party~~likely to ~~adverse~~materially toaffect, the Company’s orinternal ~~has~~control aover ~~material~~financial ~~interest adverse to the Company~~reporting.

~~ITEM 1A. RISK FACTORS~~19

~~None~~PART II – OTHER INFORMATION

~~ITEM~~Item 21. ~~UNREGISTERED~~Legal ~~SALES OF EQUITY SECURITIES AND USE OF PROCEEDS~~Proceedings

~~None~~There are no pending legal proceedings to which the Company is a party or in which any director, officer or affiliate of the Company, any owner of record or beneficially of more than 5% of any class of voting securities of the Company, or security holder is a party adverse to the Company or has a material interest adverse to the Company.

~~ITEM~~Item 31A. ~~DEFAULTS~~Risk ~~UPON SENIOR SECURITIES~~Factors

None

~~ITEM~~Item 42. ~~SUBMISSION~~Unregistered OFSales ~~MATTERS~~Of TOEquity ASecurities ~~VOTE~~And OFUse ~~SECURITIES~~Of ~~HOLDERS~~Proceeds

None

~~ITEM~~Item 53. ~~OTHER~~Defaults ~~INFORMATION~~Upon Senior Securities

During the quarter ended October 31, 2024, no director or officer of the Company adopted or terminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408(a) of Regulation S-K.None

~~ITEM~~Item 64. ~~EXHIBITS~~Mine Safety Disclosures

~~The following exhibits are included as part of this report by reference:~~None

31.1		Certification of Chief Executive Officer and Chief Financial Officer pursuant to Securities Exchange Act of 1934 Rule 13a-14(a) or 15d-14(a).
32.1		Certifications pursuant to Securities Exchange Act of 1934 Rule 13a-14(b) or 15d-14(b) and 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes- Oxley Act of 2002.

Item 5.

Other Information

22During the quarter ended January 31, 2025, no director or officer of the Company adopted or terminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408(a) of Regulation S-K.

~~SIGNATURES~~Item 6. Exhibits

InThe ~~accordance~~following ~~with~~exhibits ~~the~~are ~~requirements~~included ofas ~~the~~part ~~Securities Act~~ of ~~1933, the registrant caused~~ this report ~~to be signed on its behalf~~ by ~~the undersigned, thereunto duly authorized.~~reference:

	NAPLOY CORP.
31.1		Certification of Chief Executive Officer and Chief Financial Officer pursuant to Securities Exchange Act of 1934 Rule 13a-14(a) or 15d-14(a).
Dated: December 03, 2024	By:	/s/ Frederick Sidney Reinhard Arnold
32.1		Certifications pursuant to Securities Exchange Act of 1934 Rule 13a-14(b) or 15d-14(b) and 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes- Oxley Act of 2002.
	Name: Title:	Frederick Sidney Reinhard Arnold President, Secretary,
101.INS		Inline XBRL Instance Document
		Treasurer, Principal Executive Officer,
101.SCH		Inline XBRL Taxonomy Extension Schema Document
		Principal Financial Officer and
101.CAL		Inline XBRL Taxonomy Extension Calculation Linkbase Document
		Principal Accounting Officer and Director
101.DEF		Inline XBRL Taxonomy Extension Definition Linkbase Document
Dated: December 03, 2024	By:	/s/ Rafael Angel Ulloa Bonilla
101.LAB		Inline XBRL Taxonomy Extension Label Linkbase Document
	Name:	Rafael Angel Ulloa Bonilla
101.PRE		Inline XBRL Taxonomy Extension Presentation Linkbase Document
	Title:	Director
104		Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)

2320

SIGNATURES

In accordance with the requirements of the Securities Act of 1933, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	NAPLOY CORP.


Dated: February 27, 2025	By:	/s/ Frederick Sidney Reinhard Arnold
	Name: Title:	Frederick Sidney Reinhard Arnold President, Secretary,
		Treasurer, Principal Executive Officer,
		Principal Financial Officer and
		Principal Accounting Officer and Director

Dated: February 27, 2025	By:	/s/ Rafael Angel Ulloa Bonilla
	Name:	Rafael Angel Ulloa Bonilla
	Title:	Director

Filing Compare · Naploy Corp.